On April 12, 2024, the results of GeminiOne® for DMR were published in JACC: Case Reports, a leading journal in the field of cardiovascular interventions, which demonstrated the safety and efficacy of GeminiOne®, a TEER device independently developed by Peijia Medical. It is anticipated that the introduction of novel domestic TEER devices, such as GeminiOne®, will result in clinical benefits for a greater number of patients with moderate-to-severe or severe mitral regurgitation.
